ALPHA COGNITION Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ALPHA COGNITION, and what generic alternatives to ALPHA COGNITION drugs are available?
ALPHA COGNITION has one approved drug.
There are two US patents protecting ALPHA COGNITION drugs.
There are twenty patent family members on ALPHA COGNITION drugs in seventeen countries.
Summary for ALPHA COGNITION
| International Patents: | 20 |
| US Patents: | 2 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for ALPHA COGNITION
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alpha Cognition | ZUNVEYL | benzgalantamine gluconate | TABLET, DELAYED RELEASE;ORAL | 218549-003 | Jul 26, 2024 | RX | Yes | No | 9,763,953 | ⤷ Subscribe | ⤷ Subscribe | ||||
| Alpha Cognition | ZUNVEYL | benzgalantamine gluconate | TABLET, DELAYED RELEASE;ORAL | 218549-003 | Jul 26, 2024 | RX | Yes | No | 11,795,176 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Alpha Cognition | ZUNVEYL | benzgalantamine gluconate | TABLET, DELAYED RELEASE;ORAL | 218549-001 | Jul 26, 2024 | RX | Yes | Yes | 9,763,953 | ⤷ Subscribe | ⤷ Subscribe | ||||
| Alpha Cognition | ZUNVEYL | benzgalantamine gluconate | TABLET, DELAYED RELEASE;ORAL | 218549-002 | Jul 26, 2024 | RX | Yes | No | 11,795,176 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Alpha Cognition | ZUNVEYL | benzgalantamine gluconate | TABLET, DELAYED RELEASE;ORAL | 218549-001 | Jul 26, 2024 | RX | Yes | Yes | 11,795,176 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Alpha Cognition | ZUNVEYL | benzgalantamine gluconate | TABLET, DELAYED RELEASE;ORAL | 218549-002 | Jul 26, 2024 | RX | Yes | No | 9,763,953 | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for ALPHA COGNITION Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2024503545 | ⤷ Subscribe |
| South Korea | 20230131220 | ⤷ Subscribe |
| Israel | 303907 | ⤷ Subscribe |
| European Patent Office | 4277907 | ⤷ Subscribe |
| Mexico | 2023008276 | ⤷ Subscribe |
| European Patent Office | 4029867 | ⤷ Subscribe |
| World Intellectual Property Organization (WIPO) | 2022150917 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
